Poison Center Network Act
Author : United States. Congress. House. Committee on Energy and Commerce
Publisher :
Page : 8 pages
File Size : 41,32 MB
Release : 2014
Category : Poison control centers
ISBN :
Author : United States. Congress. House. Committee on Energy and Commerce
Publisher :
Page : 8 pages
File Size : 41,32 MB
Release : 2014
Category : Poison control centers
ISBN :
Author : United States
Publisher :
Page : 136 pages
File Size : 49,6 MB
Release : 1994
Category : Community development
ISBN :
Author : United States. Congress
Publisher :
Page : 1324 pages
File Size : 14,9 MB
Release : 1968
Category : Law
ISBN :
Author : U.S. Global Change Research Program
Publisher : Cambridge University Press
Page : 193 pages
File Size : 41,46 MB
Release : 2009-08-24
Category : Business & Economics
ISBN : 0521144078
Summarizes the science of climate change and impacts on the United States, for the public and policymakers.
Author :
Publisher :
Page : 0 pages
File Size : 14,72 MB
Release : 1911
Category : Public health laws
ISBN :
Author : United States Sentencing Commission
Publisher :
Page : 24 pages
File Size : 31,52 MB
Release : 1996-11
Category : Sentences (Criminal procedure)
ISBN :
Author : National Academies of Sciences, Engineering, and Medicine
Publisher : National Academies Press
Page : 483 pages
File Size : 38,97 MB
Release : 2017-09-28
Category : Medical
ISBN : 0309459575
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Author :
Publisher :
Page : 136 pages
File Size : 36,34 MB
Release : 1992
Category : Nitro compounds
ISBN :
Author : M. M. Peden
Publisher : World Health Organization
Page : 233 pages
File Size : 26,13 MB
Release : 2008
Category : Business & Economics
ISBN : 9241563575
Child injuries are largely absent from child survival initiatives presently on the global agenda. Through this report, the World Health Organization, the United Nations Children's Fund and many partners have set out to elevate child injury to a priority for the global public health and development communities. It should be seen as a complement to the UN Secretary-General's study on violence against children released in late 2006 (that report addressed violence-related or intentional injuries). Both reports suggest that child injury and violence prevention programs need to be integrated into child survival and other broad strategies focused on improving the lives of children. Evidence demonstrates the dramatic successes in child injury prevention in countries which have made a concerted effort. These results make a case for increasing investments in human resources and institutional capacities. Implementing proven interventions could save more than a thousand children's lives a day.--p. vii.
Author : Agency for Healthcare Research and Quality/AHRQ
Publisher : Government Printing Office
Page : 385 pages
File Size : 40,20 MB
Release : 2014-04-01
Category : Medical
ISBN : 1587634333
This User’s Guide is intended to support the design, implementation, analysis, interpretation, and quality evaluation of registries created to increase understanding of patient outcomes. For the purposes of this guide, a patient registry is an organized system that uses observational study methods to collect uniform data (clinical and other) to evaluate specified outcomes for a population defined by a particular disease, condition, or exposure, and that serves one or more predetermined scientific, clinical, or policy purposes. A registry database is a file (or files) derived from the registry. Although registries can serve many purposes, this guide focuses on registries created for one or more of the following purposes: to describe the natural history of disease, to determine clinical effectiveness or cost-effectiveness of health care products and services, to measure or monitor safety and harm, and/or to measure quality of care. Registries are classified according to how their populations are defined. For example, product registries include patients who have been exposed to biopharmaceutical products or medical devices. Health services registries consist of patients who have had a common procedure, clinical encounter, or hospitalization. Disease or condition registries are defined by patients having the same diagnosis, such as cystic fibrosis or heart failure. The User’s Guide was created by researchers affiliated with AHRQ’s Effective Health Care Program, particularly those who participated in AHRQ’s DEcIDE (Developing Evidence to Inform Decisions About Effectiveness) program. Chapters were subject to multiple internal and external independent reviews.